Roy Decker
Credentials: · · ·
History
- 2002–2003
Preliminary or Transitional Year
Research
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
Clinical Cancer Research · 2018 · 377 citations
Oncogene · 1999 · 264 citations
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 228 citations
47 papers · 31 as a resident
45 papers · 8 as a resident
29 papers
23 papers · 17 as a fellow
- FD
19 papers · 4 as a resident
18 papers
16 papers · 16 as a resident
12 papers
Grants
- 2020–2026
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
National Institute of Dental and Craniofacial Research · P50
Project lead · $469.6K · Yale University
- 2019–2025
NCI National Clinical Trials Network (NCTN) - Network Lead Academic Participating Sites
National Cancer Institute · UG1
Contact PI · $733K · Yale University
Clinical trials
- 2009–2012
Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer
Principal investigator · Completed · Phase 1
Yale University